Minghui Pharmaceutical Pty Ltd Report issue

For profit Phase 1 Phase 2
Founded: Sydney Australia (2019)

Organization Overview

First Clinical Trial
2020
NCT04689308
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

79 Qingchun Road, Shangcheng District, Hangzhou, Zhejiang, China | Minghui Pharmaceutical Pty Ltd | Minghui Pharmaceutical (Shanghai) LTD

Active Ingredients

Drugs in Phase 2 Trials (2)

mhb036c (1 trial)

mhb088c (1 trial)

Drugs in Phase 1 Trials (2)

mh004 (1 trial)

mh048 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Neoplasms (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 4
  • # of Trial APIs: 4